Tests of HIV Vaccine Using mRNA Technology Have Begun

January 27, 2022

(Medical Xpress) – Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday. This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative. Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year. (Read More)